Bingxue Shang

772 total citations
17 papers, 594 citations indexed

About

Bingxue Shang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Bingxue Shang has authored 17 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Bingxue Shang's work include Cancer, Hypoxia, and Metabolism (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Bingxue Shang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Bingxue Shang collaborates with scholars based in China, United States and Italy. Bingxue Shang's co-authors include Quansheng Zhou, Zhifei Cao, Gaochuan Zhang, Yanyan Pan, Ping Yang, Zhiwei Wang, Meimei Bao, Jian Tu, Changshun Shao and Yufang Shi and has published in prestigious journals such as Blood, Cell Death and Disease and Theranostics.

In The Last Decade

Bingxue Shang

17 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingxue Shang China 11 318 126 123 98 87 17 594
Alice Hlobílková Czechia 15 576 1.8× 170 1.3× 252 2.0× 130 1.3× 55 0.6× 26 889
Ji-Hak Jeong South Korea 15 369 1.2× 182 1.4× 151 1.2× 45 0.5× 33 0.4× 24 684
Maohua Huang China 17 364 1.1× 162 1.3× 144 1.2× 36 0.4× 20 0.2× 33 668
Peter Pyrko United States 8 399 1.3× 54 0.4× 86 0.7× 103 1.1× 58 0.7× 8 836
Huei-Mei Huang Taiwan 13 312 1.0× 53 0.4× 131 1.1× 33 0.3× 30 0.3× 23 606
Changyan Ma China 19 674 2.1× 373 3.0× 174 1.4× 50 0.5× 38 0.4× 49 945
Α. Φωτίου United Kingdom 14 339 1.1× 97 0.8× 208 1.7× 38 0.4× 40 0.5× 23 755
Alessandro Colapietro Italy 17 370 1.2× 116 0.9× 262 2.1× 55 0.6× 28 0.3× 34 728
Vineshkumar Thidil Puliyappadamba United States 14 391 1.2× 136 1.1× 161 1.3× 21 0.2× 38 0.4× 15 643

Countries citing papers authored by Bingxue Shang

Since Specialization
Citations

This map shows the geographic impact of Bingxue Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingxue Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingxue Shang more than expected).

Fields of papers citing papers by Bingxue Shang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingxue Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingxue Shang. The network helps show where Bingxue Shang may publish in the future.

Co-authorship network of co-authors of Bingxue Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Bingxue Shang. A scholar is included among the top collaborators of Bingxue Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingxue Shang. Bingxue Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wu, Sean M., et al.. (2025). Vitamin D and MAFLD: a bibliometric and visual analysis from 2007 to 2024. Frontiers in Nutrition. 12. 1558026–1558026. 1 indexed citations
2.
Meng, Mei, Yan Guo, Yu Chen, et al.. (2023). Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways. Cellular Oncology. 47(2). 657–676. 2 indexed citations
3.
Zhao, Zhe, Mei Meng, Hao Zhou, et al.. (2023). The long non-coding RNA keratin-7 antisense acts as a new tumor suppressor to inhibit tumorigenesis and enhance apoptosis in lung and breast cancers. Cell Death and Disease. 14(4). 293–293. 10 indexed citations
4.
Wang, Xuefeng, Yu Chen, Bin Lan, et al.. (2022). Heterogeneity of tyrosine-based melanin anabolism regulates pulmonary and cerebral organotropic colonization microenvironment of melanoma cells. Theranostics. 12(5). 2063–2079. 12 indexed citations
5.
Li, Xiaolei, Bingxue Shang, Yanan Li, Yufang Shi, & Changshun Shao. (2019). IFNγ and TNFα synergistically induce apoptosis of mesenchymal stem/stromal cells via the induction of nitric oxide. Stem Cell Research & Therapy. 10(1). 18–18. 65 indexed citations
6.
Shang, Bingxue, Yiyuan Pan, Jian Tu, et al.. (2014). CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis. Cell Death and Disease. 5(6). e1285–e1285. 67 indexed citations
7.
Ye, Xiantao, Lixia Wang, Bingxue Shang, Zhiwei Wang, & Wenyi Wei. (2014). NEDD4: A Promising Target for Cancer Therapy. Current Cancer Drug Targets. 14(6). 549–556. 60 indexed citations
8.
Cao, Zhifei, Bingxue Shang, Gaochuan Zhang, et al.. (2013). Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1836(2). 273–286. 84 indexed citations
9.
Cao, Zhifei, Di Yu, Gaochuan Zhang, et al.. (2013). Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity. Toxicology Letters. 218(2). 174–185. 89 indexed citations
10.
Liu, Ruifang, Bingxue Shang, Zhifei Cao, et al.. (2012). A Monoclonal Antibody SZ-117 That Recognizes Filamin A Derived from Tumor Cells. Hybridoma. 31(3). 214–218. 1 indexed citations
11.
Shang, Bingxue, Zhifei Cao, & Quansheng Zhou. (2012). Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives. Frontiers of Medicine. 6(1). 67–78. 47 indexed citations
12.
Liu, Ruifang, Zhifei Cao, Jian Tu, et al.. (2012). Lycorine hydrochloride inhibits metastatic melanoma cell‐dominant vasculogenic mimicry. Pigment Cell & Melanoma Research. 25(5). 630–638. 52 indexed citations
13.
Tu, Jian, Zhifei Cao, Yanyan Pan, et al.. (2012). Novel function of scutellarin in inhibiting cell proliferation and inducing cell apoptosis of human Burkitt lymphoma Namalwa cells. Leukemia & lymphoma. 53(12). 2456–2464. 42 indexed citations
14.
Shang, Bingxue, Gaochuan Zhang, Yanyan Pan, & Quansheng Zhou. (2012). Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy. Cancer Microenvironment. 5(3). 211–223. 8 indexed citations
15.
Zhang, Gaochuan, Bingxue Shang, Ping Yang, et al.. (2011). Induced Pluripotent Stem Cell Consensus Genes: Implication for the Risk of Tumorigenesis and Cancers in Induced Pluripotent Stem Cell Therapy. Stem Cells and Development. 21(6). 955–964. 44 indexed citations
16.
Zhou, Quansheng, Zhifei Cao, Meimei Bao, et al.. (2011). The Molecular and Cellular Processes of Tumor Cell-Mediated Tumor Angiogenesis and Vasculogenesis,. Blood. 118(21). 3267–3267. 1 indexed citations
17.
Pan, Yanyan, et al.. (2011). SZ-117, a Monoclonal Antibody Against Matrix Metalloproteinase-2 Inhibits Tumor Cell-mediated Angiogenesis. Hybridoma. 31(1). 63–67. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alice Hlobílková Breakdown of academic impact, for papers by Ji-Hak Jeong Breakdown of academic impact, for papers by Maohua Huang Breakdown of academic impact, for papers by Peter Pyrko Breakdown of academic impact, for papers by Huei-Mei Huang Breakdown of academic impact, for papers by Changyan Ma Breakdown of academic impact, for papers by Α. Φωτίου Breakdown of academic impact, for papers by Alessandro Colapietro Breakdown of academic impact, for papers by Vineshkumar Thidil Puliyappadamba
Rankless by CCL
2026